I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| natural killer cell | 12 studies | 20% ± 4% | |
| B cell | 6 studies | 21% ± 7% | |
| CD16-positive, CD56-dim natural killer cell, human | 5 studies | 18% ± 3% | |
| CD8-positive, alpha-beta T cell | 5 studies | 22% ± 3% | |
| fibroblast | 5 studies | 24% ± 7% | |
| epithelial cell | 5 studies | 39% ± 16% | |
| CD4-positive, alpha-beta T cell | 4 studies | 17% ± 2% | |
| conventional dendritic cell | 4 studies | 32% ± 14% | |
| non-classical monocyte | 4 studies | 27% ± 10% | |
| myofibroblast cell | 4 studies | 17% ± 3% | |
| pericyte | 4 studies | 23% ± 7% | |
| endothelial cell | 4 studies | 31% ± 10% | |
| ciliated cell | 4 studies | 24% ± 6% | |
| goblet cell | 4 studies | 24% ± 6% | |
| plasmacytoid dendritic cell | 4 studies | 20% ± 3% | |
| classical monocyte | 3 studies | 31% ± 8% | |
| hematopoietic precursor cell | 3 studies | 28% ± 7% | |
| smooth muscle cell | 3 studies | 24% ± 8% | |
| regulatory T cell | 3 studies | 19% ± 2% | |
| erythroblast | 3 studies | 35% ± 22% | |
| enteroendocrine cell | 3 studies | 26% ± 11% | |
| intestinal crypt stem cell | 3 studies | 19% ± 2% | |
| neuron | 3 studies | 29% ± 18% |
